Stereotactic central/core ablative radiation therapy: results of a phase I study of a novel strategy to treat bulky tumor

CONCLUSION: SCART was safely escalated to 24 GyX 3 fractions, which is the maximum Tolerated Dose (MTD) for SCART. This regimen will be used in future phase II …